Login / Signup

Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi-country severe WAPPS-Hemo haemophilia patients.

Dagmar M HajducekPierre ChelleAlfonso IorioEmma IsermanAndrea N Edginton
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Baseline usage patterns from 2017 to early 2023 provide a benchmark for assessing the impact of emerging technologies in haemophilia.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • early onset
  • patient reported outcomes
  • patient reported